| |
| Issue |
Title |
| |
| Vol 15, No 3 (2019) |
Hypertension and Headache: the Effect of Antihypertensive Drugs |
Abstract
PDF (Rus)
|
|
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova |
| |
| Vol 15, No 3 (2019) |
Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases |
Abstract
PDF (Rus)
|
|
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina |
| |
| Vol 15, No 2 (2019) |
Association between Sympathetic Nervous System Activation, Obesity and Insulin Resistance |
Abstract
PDF (Rus)
|
|
A. I. Kochetkov, O. D. Ostroumova, A. V. Starodubova, Т. М. Оstroumova, D. A. Bondarenko |
| |
| Vol 15, No 2 (2019) |
Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors |
Abstract
PDF (Rus)
|
|
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina |
| |
| Vol 15, No 2 (2019) |
Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology |
Abstract
PDF (Rus)
|
|
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova |
| |
| Vol 15, No 2 (2019) |
Cognitive impairment in patients with arterial hypertension: a relationship with the level and daily blood pressure profile and pathogenetic mechanisms |
Abstract
PDF (Rus)
|
|
T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova |
| |
| Vol 15, No 2 (2019) |
Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology |
Abstract
|
|
Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova |
| |
| Vol 15, No 1 (2019) |
Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy |
| |
| Vol 15, No 1 (2019) |
New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, E. A. Troitskaya, E. L. Kolesnik |
| |
| Vol 15, No 1 (2019) |
Atrial Tachyarrhythmias and Atrial Flutter: the Basics of Diagnostics and Modern Opportunities of Therapy |
Abstract
PDF (Rus)
|
|
Yu. A. Bunin, S. A. Miklishanskaya, E. A. Zolozova, V. V. Chigineva |
| |
| Vol 15, No 1 (2019) |
Hypertension and Dizziness: is there a Relation? |
Abstract
PDF (Rus)
|
|
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova |
| |
| Vol 14, No 6 (2018) |
The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial |
Abstract
PDF (Eng)
|
|
Yu. A. Karpov |
| |
| Vol 14, No 6 (2018) |
P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel |
Abstract
PDF (Eng)
|
|
N. M. Vorobyeva |
| |
| Vol 14, No 6 (2018) |
Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem |
Abstract
PDF (Eng)
|
|
N. M. Vorobyeva, O. N. Tkacheva |
| |
| Vol 14, No 6 (2018) |
Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues |
Abstract
PDF (Eng)
|
|
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan |
| |
| Vol 14, No 5 (2018) |
Orthostatic Hypotension: Definition, Pathophysiology, Classification, Prognostic Aspects, Diagnostics and Treatment |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, M. S. Cherniaeva, M. M. Petrova, O. V. Golovina |
| |
| Vol 14, No 5 (2018) |
Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria |
Abstract
PDF (Rus)
|
|
Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta |
| |
| Vol 14, No 5 (2018) |
Myocardial Infarction with Nonobstructive Coronary Arteries (МINОСА) – a Trendy Term or a New Diagnostic Concept? |
Abstract
PDF (Rus)
|
|
S. S. Yakushin |
| |
| Vol 14, No 5 (2018) |
Arterial Hypertension in Older Adults in the Light of New European Guidelines 2018 |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, M. S. Cherniaeva |
| |
| Vol 14, No 4 (2018) |
Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice |
Abstract
PDF (Rus)
|
|
N. M. Vorobyeva, O. N. kacheva |
| |
| Vol 14, No 4 (2018) |
Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases |
Abstract
PDF (Rus)
|
|
O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin |
| |
| Vol 14, No 4 (2018) |
Abnormal Microcirculation and Red Blood Cell Function as a Cardiovascular Risk Factor in Metabolic Syndrome |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, T. V. Koroleva, M. V. Pisarev, M. G. Kudryavtseva, D. A. Zateyshchikova |
| |
| Vol 14, No 4 (2018) |
Takotsubo Syndrome: Contemporary Views on the Pathogenesis, Prevalence and Prognosis |
Abstract
PDF (Rus)
|
|
A. S. Shilova, A. O. Shmotkina, A. A. Yafarova, M. Yu. Gilyarov |
| |
| Vol 14, No 4 (2018) |
Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment |
Abstract
PDF (Rus)
|
|
Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova |
| |
| Vol 14, No 3 (2018) |
THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova |
| |
| Vol 14, No 3 (2018) |
HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE |
Abstract
PDF (Rus)
|
|
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta |
| |
| Vol 14, No 3 (2018) |
APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova |
| |
| Vol 14, No 3 (2018) |
NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES |
Abstract
PDF (Rus)
|
|
G. S. Galjautdinov1, I. V. Gorelkin, K. R. Ibragimova, R. R. Sadriev |
| |
| Vol 14, No 2 (2018) |
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM MINIMIZATION OF EXPENSES TO EFFECTIVE MANAGEMENT |
Abstract
PDF (Rus)
|
|
N. A. Nikolayev, Yu. P. Skirdenko, S. S. Bunova, A. V. Ershov |
| |
| Vol 14, No 2 (2018) |
New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion |
Abstract
PDF (Rus)
|
|
A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko |
| |
| Vol 14, No 2 (2018) |
WHAT ARE THE OPPORTUNITIES OF PRASUGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME |
Abstract
PDF (Rus)
|
|
M. Yu. Gilyarov, Е. V. Konstantinova |
| |
| Vol 14, No 1 (2018) |
RESPONSIBLE SELF-CARE – THE FUNDAMENTAL PRINCIPLES AND PLACE IN THE MODERN RUSSIAN HEALTHCARE SYSTEM |
Abstract
PDF (Rus)
|
|
S. N. Tolpygina, S. Yu. Martsevich, A. V. Kontsevaya, O. M. Drapkina |
| |
| Vol 14, No 1 (2018) |
PROBLEMS OF EVALUATING BLOOD PRESSURE MEASUREMENT IN MODERN CLINICAL TRIALS (THE CASE OF SPRINT STUDY RESULTS) |
Abstract
PDF (Rus)
|
|
V. M. Gorbunov |
| |
| Vol 14, No 1 (2018) |
SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva |
| |
| Vol 13, No 6 (2017) |
SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina |
| |
| Vol 13, No 6 (2017) |
INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuzmina |
| |
| Vol 13, No 6 (2017) |
ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY |
Abstract
PDF (Rus)
|
|
Yu. А. Bunin, S. V. Miklishanskaya |
| |
| Vol 13, No 6 (2017) |
ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. Part 2. Antihypertensive and Organoprotective Effects of Amlodipine/Lisinopril Fixed-Dose Combination in Patients with Arterial Hypertension in the Presence of Overweight and Obesity |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina |
| |
| Vol 13, No 6 (2017) |
FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES |
Abstract
PDF (Rus)
|
|
D. А. Napalkov, A. A. Sokolova |
| |
| Vol 13, No 5 (2017) |
ADHERENCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION – THE WAY TO SOLVE THE PROBLEM OF EFFICACY AND SAFETY OF TREATMENT |
Abstract
PDF (Rus)
|
|
S. G. Kanorskii |
| |
| Vol 13, No 5 (2017) |
WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT |
Abstract
PDF (Rus)
|
|
S. Yu. Martsevich, Y. V. Lukina |
| |
| Vol 13, No 5 (2017) |
ARTERIAL HYPERTENSION IN THE PRESENCE OF OVERWEIGHT AND OBESITY. THE CAPABILITIES OF AMLODIPINE AND LISINOPRIL COMBINATION. PART 1. FEATURES OF THE DAILY PROFILE OF BLOOD PRESSURE AND HEART DAMAGE AS A TARGET ORGAN IN PATIENTS WITH ARTERIAL HYPERTENSION IN COMBINATION WITH OVERWEIGHT AND OBESITY |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchjonov, V. M. Fomina |
| |
| Vol 13, No 5 (2017) |
Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells |
Abstract
|
|
Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov |
| |
| Vol 13, No 4 (2017) |
HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? |
Abstract
PDF (Rus)
|
|
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova |
| |
| Vol 13, No 4 (2017) |
ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, E. V. Kokhan, G. K. Kiyakbaev, A. A. Shavarov |
| |
| Vol 13, No 3 (2017) |
ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION |
Abstract
PDF (Rus)
|
|
F. I. Belyalov |
| |
| Vol 13, No 3 (2017) |
THE PREVALENCE AND CLINICAL SIGNIFICANCE OF CARDIAC ARRHYTHMIAS |
Abstract
PDF (Rus)
|
|
E. V. Zatonskaya, G. V. Matyushin, N. G. Gogolashvili |
| |
| Vol 13, No 3 (2017) |
HYPERTHYROIDISM AND ATRIAL FIBRILLATION |
Abstract
PDF (Rus)
|
|
I. M. Marusenko, E. G. Petrova |
| |
| Vol 13, No 3 (2017) |
HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY |
Abstract
PDF (Rus)
|
|
O. A. Kislyak, A. V. Starodubova, A. A. Kopelev |
| |
| Vol 13, No 3 (2017) |
ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, M. V. Pisarev |
| |
| Vol 13, No 2 (2017) |
ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES |
Abstract
PDF (Rus)
|
|
S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko |
| |
| Vol 13, No 2 (2017) |
ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE |
Abstract
PDF (Rus)
|
|
V. I. Podzolkov, N. A. Dragomiretskaya |
| |
| Vol 13, No 1 (2017) |
DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT |
Abstract
PDF (Rus)
|
|
D. А. Napalkov, A. A. Sokolova, V. V. Fomin |
| |
| Vol 13, No 1 (2017) |
THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, R. N. Shepel |
| |
| Vol 13, No 1 (2017) |
MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE |
Abstract
PDF (Rus)
|
|
N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya |
| |
| Vol 13, No 1 (2017) |
Рекомендации по совместному назначению статинов и урсодезоксихолевой кислоты пациентам с высоким риском сердечно-сосудистых осложнений и сопутствующей неалкогольной жировой болезнью печени: проблемы практического применения |
Abstract
|
|
|
| |
| Vol 12, No 6 (2016) |
HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT |
Abstract
PDF (Rus)
|
|
B. U. Mardanov, M. N. Korneeva, E. B. Akhmedova |
| |
| Vol 12, No 6 (2016) |
CURRENT METHODS OF ENDOTHELIAL DYSFUNCTION ASSESSMENT AND THEIR POSSIBLE USE IN THE PRACTICAL MEDICINE |
Abstract
PDF (Rus)
|
|
A. V. Shabrov, A. G. Apresyan, A. L. Dobkes, S. U. Ermolov, T. V. Ermolova, S. G. Manasyan, S. V. Serdyukov |
| |
| Vol 12, No 6 (2016) |
ROLE OF NON-DRUG THERAPIES OF METABOLIC SYNDROME: CHALLENGES AND PROSPECTS |
Abstract
PDF (Rus)
|
|
S. N. Strelkova, K. V. Ovsyannicov, N. I. Utkina |
| |
| Vol 12, No 5 (2016) |
Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease |
Abstract
PDF (Rus)
|
|
I. S. Daabul, A. A. Sokolova, D. A. Napalkov |
| |
| Vol 12, No 5 (2016) |
Pathogenic Mechanisms of Atrial Fibrillation in Obesity |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, M. V. Nikolaeva |
| |
| Vol 12, No 5 (2016) |
Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation |
Abstract
PDF (Rus)
|
|
N. A. Novikova, A. N. Volovchenko |
| |
| Vol 12, No 4 (2016) |
Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation |
Abstract
PDF (Rus)
|
|
S. G. Kanorskii |
| |
| Vol 12, No 4 (2016) |
Fighting with obesity: the "gold standard" and new horizons |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov |
| |
| Vol 12, No 4 (2016) |
Resistant hypertension: epidemiology and risk factors |
Abstract
PDF (Rus)
|
|
I. E. Deneka, A. A. Svetankova, A. V. Rodionov |
| |
| Vol 12, No 4 (2016) |
Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true |
Abstract
PDF (Rus)
|
|
Yu. A. Bunin, S. V. Miklishanskaya |
| |
| Vol 12, No 3 (2016) |
Проблема назначения статинов больным с сердечно-сосудистыми заболеваниями и сопутствующими болезнями печени. Что препятствует преодолению статинофобии? |
Abstract
|
|
|
| |
| Vol 12, No 3 (2016) |
NEW METHODS OF ASSESSMENT OF SUBCLINICAL CHANGES IN THE CARDIOVASCULAR SYSTEM IN ARTERIAL HYPERTENSION |
Abstract
PDF (Eng)
|
|
Zh. D. Kobalava, Yu. V. Kotovskaya, A. V. Bogomaz |
| |
| Vol 12, No 3 (2016) |
THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? |
Abstract
PDF (Eng)
|
|
S. N. Bel'diev |
| |
| Vol 12, No 3 (2016) |
GENETIC PREDICTORS OF ATRIAL FIBRILLATION |
Abstract
PDF (Eng)
|
|
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina |
| |
| Vol 12, No 3 (2016) |
THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT |
Abstract
PDF (Eng)
|
|
S. R. Gilyarevskiy |
| |
| Vol 12, No 2 (2016) |
ESTIMATION OF HIGHLY SENSITIVE TROPONIN TESTS IN THE DIAGNOSIS OF ACUTE CORONARY SYNDROME |
Abstract
PDF (Rus)
|
|
L. V. Kremneva, S. N. Suplotov, S. V. Shalaev |
| |
| Vol 12, No 2 (2016) |
ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION |
Abstract
PDF (Rus)
|
|
Ju. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolaev |
| |
| Vol 12, No 2 (2016) |
ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? |
Abstract
PDF (Rus)
|
|
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov |
| |
| Vol 12, No 2 (2016) |
THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES |
Abstract
PDF (Rus)
|
|
M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov |
| |
| Vol 12, No 1 (2016) |
Pharmacotherapy of pulmonary hypertension (according to the 2015 ESC/EAS Guidelines for the diagnosis and treatment of pulmonary hypertension) |
Abstract
PDF (Eng)
PDF (Rus)
|
|
E. L. Trisvetova, S. V. Gubkin |
| |
| Vol 12, No 1 (2016) |
Effect of magnesium on the cardiovascular system in women |
Abstract
PDF (Eng)
PDF (Rus)
|
|
E. A. Ulubieva, A. G. Avtandilov |
| |
| Vol 12, No 1 (2016) |
Acute coronary syndrome and renal dysfunction |
Abstract
PDF (Rus)
|
|
F. I. Belyalov |
| |
| Vol 4, No 5 (2008) |
CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE |
Abstract
PDF (Rus)
|
|
M. V. Soura |
| |
| Vol 4, No 5 (2008) |
INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS |
Abstract
PDF (Rus)
|
|
V. V. Fomin |
| |
| Vol 4, No 4 (2008) |
PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY |
Abstract
PDF (Rus)
|
|
S. A. Boytsov, I. P. Kolos |
| |
| Vol 4, No 4 (2008) |
CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS |
Abstract
PDF (Rus)
|
|
S. Y. Martsevich |
| |
| Vol 4, No 4 (2008) |
INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK |
Abstract
PDF (Rus)
|
|
N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky |
| |
| Vol 4, No 4 (2008) |
BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST |
Abstract
PDF (Rus)
|
|
L. N. Malaj |
| |
| Vol 4, No 3 (2008) |
ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS |
Abstract
PDF (Rus)
|
|
V. A. Sulimov |
| |
| Vol 4, No 3 (2008) |
ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW? |
Abstract
PDF (Rus)
|
|
S. Y. Martsevich |
| |
| Vol 4, No 3 (2008) |
ANGIOTENSIN II AND MYOCARDIAL INFARCTION |
Abstract
PDF (Rus)
|
|
O. P. Shevchenko, А. О. Shevchenko |
| |
| Vol 4, No 2 (2008) |
DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES |
Abstract
PDF (Rus)
|
|
E. V. Shilova, S. Y. Martsevich |
| |
| Vol 4, No 2 (2008) |
ACUTE CORONARY SYNDROME IN PATIENTS WITH DIABETES MELLITUS: ON THE WAY TO MUNICH-2008 |
Abstract
PDF (Rus)
|
|
I. I. Dedov, A. A. Alexanrov |
| |
| Vol 4, No 2 (2008) |
ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? |
Abstract
PDF (Rus)
|
|
A. L. Komarov, E. P. Panchenko |
| |
| Vol 4, No 1 (2008) |
ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? |
Abstract
PDF (Rus)
|
|
S. Y. Martsevich, N. P. Kutishenko |
| |
| Vol 4, No 1 (2008) |
WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL |
Abstract
PDF (Rus)
|
|
M. N. Mamedov, M. B. Stroeva |
| |
| Vol 4, No 1 (2008) |
EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL” |
Abstract
PDF (Rus)
|
|
статья Редакционная |
| |
| Vol 2, No 3 (2006) |
ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? |
Abstract
PDF (Rus)
|
|
I. A. Latfullin, A. A. Podolskaya |
| |
| Vol 2, No 3 (2006) |
CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES |
Abstract
PDF (Rus)
|
|
P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian |
| |
| Vol 2, No 3 (2006) |
EFFICACY OF THERAPY WITH INDIRECT ANTICOAGULANTS: ROLE OF THE FOODSTUFF VITAMIN K CONTENTS |
Abstract
PDF (Rus)
|
|
A. P. Momot, O. V. Bespalova, E. N. Vorobyova |
| |
| Vol 2, No 4 (2006) |
QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? |
Abstract
PDF (Rus)
|
|
V. V. Iakusevich |
| |
| Vol 2, No 4 (2006) |
FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS |
Abstract
PDF (Rus)
|
|
Yu. M. Lopatin |
| |
| Vol 2, No 4 (2006) |
CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY |
Abstract
PDF (Rus)
|
|
R. I. Striuk |
| |
| Vol 7, No 6 (2011) |
DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| 101 - 200 of 342 Items |
<< < 1 2 3 4 > >>
|
